to-BBB总部位於荷兰，主要从事开发针对脑部给药技术及产品的公司，并已取得全球独家开发及经营G-Technology脑部给药技术的专利权。至於G-Technology是一安全有效的脑部药物传输技术，增强药物通过血脑屏障，旨在治疗损伤性中枢神经系统疾病。

to-BBB is a clinical stage biotechnology company focusing on enhanced drug delivery across the blood-brain barrier. The Company is developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases, by combining existing drugs with the G-Technology®, to-BBB's proprietary brain delivery platform.